Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.35 $95 - $145
-415 Reduced 0.45%
91,099 $26,000
Q3 2021

Nov 12, 2021

SELL
$0.99 - $1.38 $16,830 - $23,460
-17,000 Reduced 15.67%
91,514 $94,000
Q2 2021

Aug 11, 2021

SELL
$1.14 - $1.87 $150,248 - $246,460
-131,797 Reduced 54.84%
108,514 $136,000
Q1 2021

May 13, 2021

BUY
$1.34 - $3.53 $2,805 - $7,391
2,094 Added 0.88%
240,311 $427,000
Q4 2020

Feb 09, 2021

SELL
$0.87 - $1.26 $7,184 - $10,405
-8,258 Reduced 3.35%
238,217 $290,000
Q2 2020

Aug 12, 2020

SELL
$0.97 - $1.7 $22,468 - $39,377
-23,163 Reduced 8.59%
246,475 $327,000
Q1 2020

May 06, 2020

SELL
$0.9 - $1.95 $993 - $2,152
-1,104 Reduced 0.41%
269,638 $296,000
Q4 2019

Feb 14, 2020

SELL
$1.0 - $1.49 $6,000 - $8,940
-6,000 Reduced 2.17%
270,742 $379,000
Q3 2019

Nov 07, 2019

SELL
$0.97 - $1.77 $28,573 - $52,138
-29,457 Reduced 9.62%
276,742 $329,000
Q2 2019

Aug 12, 2019

BUY
$0.96 - $1.89 $16,486 - $32,456
17,173 Added 5.94%
306,199 $374,000
Q1 2019

May 14, 2019

SELL
$1.76 - $3.73 $1,395 - $2,957
-793 Reduced 0.27%
289,026 $509,000
Q4 2018

Feb 11, 2019

BUY
$2.01 - $4.21 $412,652 - $864,313
205,300 Added 242.9%
289,819 $1.07 Million
Q2 2018

Aug 06, 2018

BUY
$2.05 - $4.09 $173,263 - $345,682
84,519 New
84,519 $267,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.